Megna Michael R sold KNSA
August 4, 2025 · Form 4 insider transaction
Megna Michael R sold 17,000 shares of Kiniksa Pharmaceuticals International, plc at $32.35 per share, a transaction worth $550.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
17,000
Price
$32.35
Total value
$550.0K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateAugust 4, 2025
Filing dateAugust 6, 2025
Shares owned after33,041
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.01 and $32.895. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.